Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Chimeric antigen receptor-T-cellebehandling

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ruptur af brystimplantat kan imitere dissemineret cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nyankomne flygtninge lider af infektionssygdomme, mangeltilstande og psykisk mistrivsel

    Research output: Contribution to journalReviewResearchpeer-review

  3. Traumer og psykiske lidelser hos nyankomne flygtninge

    Research output: Contribution to journalEditorialResearch

  4. Behandling af navlebrok hos patienter med cirrose

    Research output: Contribution to journalReviewResearchpeer-review

  5. Spontan lavtrykshovedpine kan forveksles med traumatisk subduralt hæmatom

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Real-world data on melanoma brain metastases and survival outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?

    Research output: Contribution to journalReviewResearchpeer-review

  3. Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Although treatment of haematological cancer has improved significantly during the latest decades, the prognosis is poor in case of relapse or refractory disease. This review describes the chimeric antigen receptor (CAR) T-cell therapy, which has emerged as a new promising treatment principle, in which the patient's own T-cells are genetically modified to recognise cancer cells. The possible side effects are usually only transient. A commercial CD19 CAR T-cell product has recently been approved as treatment for acute lympho-blastic leukaemia in children and young adults in Denmark, and a non-commercial CAR T-cell production is being established.

Original languageEnglish
JournalUgeskrift for Laeger
Volume181
Issue number20A
ISSN0041-5782
Publication statusPublished - 14 Oct 2019

ID: 58521171